-
Looking to the Future - -
| Artigo | Autor(es) | Referência |
|---|---|---|
| Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non-Small-Cell Lung Cancer. | Oxnard Geoffrey R, Thress Kenneth S, Alden Ryan S, Lawrance Rachael, Paweletz Cloud P, Cantarini Mireille, Yang James Chih-Hsin, Barrett J Carl, Jänne Pasi A | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 10; 34(10):3375-82. doi: 10.1200/JCO.2016.66.7162. pii: . |
| Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. | Tie Jeanne, Wang Yuxuan, Tomasetti Cristian, Li Lu, Springer Simeon, Kinde Isaac, Silliman Natalie, Tacey Mark, Wong Hui-Li, Christie Michael, Kosmider Suzanne, Skinner Iain, Wong Rachel, Steel Malcolm, Tran Ben, Desai Jayesh, Jones Ian, Haydon Andrew, Hayes Theresa, Price Tim J, Strausberg Robert L, Diaz Luis A, Papadopoulos Nickolas, Kinzler Kenneth W, Vogelstein Bert, Gibbs Peter | Science translational medicine. 2016 07; 8(07):346ra92. doi: 10.1126/scitranslmed.aaf6219. pii: . |
| Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer. | Sacher Adrian G, Paweletz Cloud, Dahlberg Suzanne E, Alden Ryan S, O'Connell Allison, Feeney Nora, Mach Stacy L, Jänne Pasi A, Oxnard Geoffrey R | JAMA oncology. 2016 Aug; 2(Aug):1014-22. doi: 10.1001/jamaoncol.2016.0173. pii: . |